Association of Epstein-Barr virus latently expressed genes with multiple sclerosis

Mult Scler Relat Disord. 2021 Jul:52:103008. doi: 10.1016/j.msard.2021.103008. Epub 2021 May 7.

Abstract

Background: Despite mounting evidence supporting an etiologic role for Epstein-Barr virus (EBV) in multiple sclerosis (MS), the exact mechanisms through which the virus may contribute to disease development are still unknown. The aim of this study was to analyze seven highly polymorphic EBV latently expressed genes in individuals diagnosed with MS in comparison to healthy controls (HC), to investigate the possible association of EBV variants with an individual's risk towards MS.

Methods: B-lymphocytes were isolated from MS patients (n = 30) and HC (n = 33) for the isolation of EBV genomic DNA. Sanger sequencing was employed to analyze EBV latent gene regions.

Results: A total of 26 variants were detected in our cohort, 17 of which were significantly associated with the MS group while nine were significantly associated with HC. Following the designation of EBV alleles based on these variants, MS risk was found to be significantly associated with the presence of the EBNA3B2.1 allele (p = 0.0008) and LMP1.1 allele (p = 0.01), whereas the EBNA1.3 allele (p = 0.005), EBNA2.1 allele (p = 0.001) as well as the EBNA3B2.2 allele (p = 0.0003) appeared to provide a protective role.

Conclusions: This study indicates a marked association between EBV genetic variants and MS, lending further support towards possible molecular mechanisms through which EBV may contribute to disease development.

Keywords: Environmental risk factor; Epstein Barr-virus; Genetic variants; Latency; Multiple sclerosis.

MeSH terms

  • B-Lymphocytes
  • Epstein-Barr Virus Infections*
  • Epstein-Barr Virus Nuclear Antigens
  • Herpesvirus 4, Human
  • Humans
  • Multiple Sclerosis*
  • Viral Proteins

Substances

  • Epstein-Barr Virus Nuclear Antigens
  • Viral Proteins